Patient P-02173
Synthetic patientMETA-24 · Day 175 · 45–54 · F · baseline S07Steering view · 3DOpen companion preview
Therapy response
Favorable
Tolerance
Deteriorating
GI state
Improving
Inflammatory state
Improving
Nutritional resilience
Improving
Discontinuation risk
2%
Trajectory
Baseline → today → 30-day prediction · hover a day for signals and eventssolid = observed · dashed = predicted
- Day 0 META-24 started — Baseline state S07
- Day 106 CR-01 recommended — Clinician Review CR-01
- Day 107 Patient declined — Not now
What changed?
Trajectory is tracking the baseline prediction.
Primary contributors, last 14 days
- GI instability-15
- Nutritional resilience+9
- Inflammatory activity-5
- Toxicity+5
- Treatment adherence-2
What helped?
- Clinician Review CR-01Day 106Declined by patient
LIFE OS recommendation
No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.
Daily trackers
Molecule settingsThe trackers this program marks as important, last 14 days vs the 14 before.
Active minutes
Wearable69 min
stable · +1.6 vs previous 14 d
Sleep duration
Wearable7.3 h
stable · +0.1 vs previous 14 d
Energy level
Daily log7.2/10
improving · +0.4 vs previous 14 d
Steps
Wearable8,193
improving · +861 vs previous 14 d
GI burden
Companion5.7/100
improving · -5.6 vs previous 14 d
Adherence
Companion92 %
stable · -3.0 vs previous 14 d
Sleep quality
Wearable56/100
improving · +2.5 vs previous 14 d
Glucose, CGM daily mean
CGM115 mg/dL
stable · -4.7 vs previous 14 d
This trajectory is decaying — what would help, what would not
Steering view →Heading towards restoration · 102 from the failing basin, 16 from restoration.
Would help
- No untried action with strong evidence. Compose one from primitives.
- More proteinGI -5.9 next day on high-intake days · n 19
Would not help
- Nothing clearly counter-productive in the record.
State influencers · digestive
Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.
- Protein-5.9supporter · 95%
- Caffeine-2.5no signal · 55%
- Simple carbohydrates-2.1no signal · 45%
- Ultra-processed food-1.6no signal · 35%
- Alcohol-1.3no signal · 32%
- Histamine load-0.8no signal · 20%
- Dietary fat load-0.5no signal · 15%
- Insoluble fibre+0.1no signal · 15%
Biological layers
Which pathways look influenced, and by which layer of this person's biology.
Pathways under pressure
- Mucosal barrier integrity ↓30
- MicrobiomeAkkermansia low → thinner mucus layer
- Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion
DNA
Fictional pharmacogenomic panel
- CYP2D6 Rapid metabolizerExpected exposure
Microbiome
Shannon diversity 3.8 · butyrate capacity 45/100
- Akkermansia muciniphilaLow
- Faecalibacterium prausnitziiNormal
- Bacteroides fragilisHigh
- Bifidobacterium longumNormal
- EnterobacteriaceaeNormal
Wearable, last 14 days
daily evolution fed into the runtime
- HRV
- 39 ms
- Sleep
- 6.7 h
- Steps
- 8,522
- Resting HR
- 58 bpm
Daily log: GI score 6, nutritional resilience 79, adherence 92.
What this patient sees in NostraAI
The content that steers the trajectory: what to eat, what to do, what to take.
What to eat
- Keep meals regular; three to four moderate portions spaced through the day
- Include a cooked vegetable portion with each main meal
- Keep fibre steady; no new sources this week
- Eat slowly and stop at comfortable fullness — smaller volume, more often
What to do
- Log the daily check-in; one line is enough
- Keep the current walking rhythm
- Keep the sleep window steady
- Keep hydration steady: small amounts through the day rather than large volumes at once
What to take
- Take the dose at the same time relative to your evening meal
- No additional supplements this week
- Fictional demo item: continue vitamin D as before
284 biologically similar trajectories
Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.
| Patient | Similarity | Baseline | Intervention | Outcome | Response today |
|---|---|---|---|---|---|
| P-02337 | 34% | S18 | DT-01 | no change | 100 |
| P-02249 | 40% | S09 | DT-01 | improved | 100 |
| P-02189 | 38% | S17 | — | — | 96 |
| P-02640 | 35% | S03 | — | — | 96 |
| P-02242 | 35% | S20 | — | — | 95 |
| P-02013 | 40% | S14 | BR-03 | no change | 94 |
| P-02104 | 40% | S15 | — | — | 94 |
| P-02450 | 41% | S12 | NP-02 | improved | 92 |
| P-02277 | 44% | S05 | AD-05 | improved | 92 |
| P-02304 | 38% | S15 | — | — | 92 |
| P-02653 | 33% | S14 | — | — | 91 |
| P-02689 | 31% | S13 | — | — | 91 |